Variant report
Variant | nsv1038262 |
---|---|
Chromosome Location | chr14:24488131-24500117 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141974497 | chr14:24488131-24488132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs200853147 | chr14:24488143-24488144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201753842 | chr14:24488152-24488153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573215906 | chr14:24488159-24488160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs376698415 | chr14:24492831-24492832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528360465 | chr14:24492841-24492842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138413900 | chr14:24492842-24492843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs370291306 | chr14:24492852-24492853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143003412 | chr14:24492855-24492856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs177948 | chr14:24492886-24492887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530321713 | chr14:24492902-24492903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs564137434 | chr14:24492921-24492922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371248699 | chr14:24492924-24492925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146088239 | chr14:24492948-24492949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs180742502 | chr14:24492964-24492965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375678543 | chr14:24492989-24492990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569670817 | chr14:24492999-24493000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529421173 | chr14:24493041-24493042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370318818 | chr14:24493057-24493058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549324861 | chr14:24493059-24493060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369278356 | chr14:24493069-24493070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534983348 | chr14:24493082-24493083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558473124 | chr14:24493084-24493085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373275300 | chr14:24493089-24493090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537053051 | chr14:24493111-24493112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557048733 | chr14:24493129-24493130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149766058 | chr14:24493154-24493155 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
28 | rs368140402 | chr14:24493158-24493159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570899505 | chr14:24493177-24493178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs386775667 | chr14:24493206-24493207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs202097004 | chr14:24493208-24493209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200585454 | chr14:24493209-24493210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544968437 | chr14:24493212-24493213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs564847390 | chr14:24493215-24493216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577571180 | chr14:24493232-24493233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543436309 | chr14:24493256-24493257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563404240 | chr14:24493271-24493272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529351026 | chr14:24493357-24493358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs372173356 | chr14:24493371-24493372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549482709 | chr14:24493404-24493405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs186508548 | chr14:24493421-24493422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534628421 | chr14:24493448-24493449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528723784 | chr14:24493479-24493480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552062236 | chr14:24493536-24493537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368824390 | chr14:24493614-24493615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144690183 | chr14:24493621-24493622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190849440 | chr14:24493625-24493626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1957681 | chr14:24493675-24493676 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs550580356 | chr14:24493683-24493684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538501037 | chr14:24493697-24493698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Lung cancer | 16773561 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17440070 | CNVD |
Breast cancer | 16272173 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Epilepsy | 20736978 | CNVD |
Mental retardation | 20736978 | CNVD |
severe speech impairment | 20736978 | CNVD |
speech impairment | 20736978 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Cancer | 21183584 | CNVD |
Leukoplakia | 24403051 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:24483800-24488200 | Weak transcription | Dnd41 | blood |
2 | chr14:24492800-24494600 | Enhancers | HepG2 | liver |
3 | chr14:24494000-24494600 | Enhancers | Liver | Liver |
4 | chr14:24494400-24495600 | Enhancers | Dnd41 | blood |
5 | chr14:24495600-24500000 | Weak transcription | Dnd41 | blood |
6 | chr14:24500000-24500400 | Enhancers | Dnd41 | blood |